Analytical Data
-
基因名
CD99L2
- Application
-
别名
C99L2_HUMAN; CD99; CD99 antigen-like Protein 2; CD99L2; MIC2-like Protein 1; MIC2L1
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q8TCZ2
-
表达区间
1-145aa
-
氨基酸序列
MVAWRSAFLVCLAFSLATLVQRGSGDFDDFNLEDAVKETSSVKPALGMYHKLDGLKQQNFILSLFWMLEVLYQGVGWATFSLKALGKNLSLTFPTSGGSRCSLVCGCITPISASVVTWCSPFCVSLLSLTKMLVSGFKAHLDNPG
-
分子量
42.1 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant E.coli hdhA Protein，His
Cat：PA2000-2888
Recombinant Human RPL4 Protein，His
Cat：PAX2000-11031
Protein Description
CD99L2, a member of the CD99 family of proteins, has garnered significant interest in recent years due to its potential roles in immune response and cellular adhesion. It is primarily expressed in various tissues, including the heart, brain, and hematopoietic cells, suggesting a pivotal function in both physiological and pathological conditions. Research has indicated that CD99L2 may be involved in modulating immune cell interactions, influencing T-cell activation, and participating in inflammatory responses. Given its expression patterns and functional associations, the recombinant protein of CD99L2 has been studied for its potential applications in immunotherapy and cancer treatment. Understanding the molecular mechanisms underlying CD99L2's activities could offer new insights into the development of therapeutic strategies for diseases where immune dysregulation plays a critical role. Moreover, the generation and characterization of recombinant CD99L2 protein provide valuable tools for further exploration of its biological functions and interactions with other cell surface molecules, thereby enhancing our comprehension of its contributions to human health and disease.
